Highlights

Good Articles to Share

Author: Tan KW   |   Latest post: Mon, 25 Jan 2021, 3:15 PM

 

Russia says India to produce 100 million doses of Sputnik vaccine

Author:   |    Publish date:


MOSCOW: One of the developers of Russia's Sputnik V coronavirus vaccine announced on Friday that India-based drugmaker Hetero will produce over 100 million doses of the jab.
 
"Hetero, one of India's leading generic pharmaceutical companies, have agreed to produce in India over 100 million doses per year of the world's first registered vaccine against the novel coronavirus infection – Sputnik V," the Russian Direct Investment Fund (RDIF) said in a statement, adding that production was expected to start in early 2021.
 
Earlier this week, Russia said interim results from the Sputnik V clinical trails showed the vaccine was 95 per cent effective, similar to other international vaccine makers that have also published test results showing efficacy rates of 90 per cent and higher.
 
Russia also announced that the Sputnik V vaccine will be priced at US$10 per dose on international markets, costing less than some other registered Covid-19 vaccines. 
 
Russia was the first country to announce the registration of a coronavirus vaccine in August – dubbed Sputnik V after the Soviet-era satellite – but did so ahead of large scale clinical trials.
 
Currently, the third and final phase of trials is underway, with some 40,000 volunteers involved in blind testing of the vaccine that uses two different human adenovirus vectors.
 
According to Friday's statement, their use "allows for a stronger and longer-term immune response" compared to vaccines that use the same vector in both its doses.
 
Third phase trials are also underway in the ex-Soviet republic of Belarus, the UAE and Venezuela among other countries.
 
Apart from India, the RDIF says Sputnik V will also be produced in Brazil, China and South Korea.
 
"I am confident that Sputnik V should become an integral part of the national vaccine portfolio of every country willing to protect its population from the coronavirus," RDIF head Kirill Dmitriyev was quoted as saying in Friday's statement.
 
 - AFP
 
Share this

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View Trading Signals and run Live Backtest
MQ Affiliate
Earn rewards with MQ Affiliate Program
 
 

164  876  563  911 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 DNEX 0.29+0.03 
 DNEX-WD 0.055+0.01 
 XOX 0.08-0.01 
 PHB 0.03+0.005 
 XOX-WC 0.02+0.015 
 BIOHLDG 0.28-0.02 
 QES 0.36-0.02 
 LUSTER 0.195+0.01 
 VIZIONE 0.225-0.045 
 SAPNRG 0.120.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax record profit must prevail - Koon Yew Yin Koon Yew Yin's Blog
2. Eurocham: No mention of lockdown after Feb 4 in meeting with Miti save malaysia!
3. Jaks Resources - Final Update :- Jaks Hai Duong Power Plant achieved FULL COD ! DK
4. Biden Presidency Spells Good Times for Malaysian Gloves Trying to Make Sense Bursa Investments
5. Tan Sri Lim: “Being sick is being abnormal.” TOPGLOV allows only 2 paid sick leave p.a. LHL please make a police report if what you says is true! gloveharicut
6. CIMB: FREIGHT is trading at a 60.9% & 30.8% discount to its local & regional peers gloveharicut
7. Bargain hunting lifts GLOVEs share prices, say analyst, fund manager as situation remains 'volatile' gloveharicut
8. Top Glove: Allegations of management hypocrisy and lack of integrity By LHL save malaysia!
PARTNERS & BROKERS